JP2016515133A5 - - Google Patents

Info

Publication number

JP2016515133A5

JP2016515133A5 JP2016502428A JP2016502428A JP2016515133A5 JP 2016515133 A5 JP2016515133 A5 JP 2016515133A5 JP 2016502428 A JP2016502428 A JP 2016502428A JP 2016502428 A JP2016502428 A JP 2016502428A JP 2016515133 A5 JP2016515133 A5 JP 2016515133A5

Authority

JP

Japan

Prior art keywords

seq

vaccine vector

polypeptide

species

group

Prior art date

2014-03-14

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 229960005486 vaccine Drugs 0.000 claims description 54
• 229920001184 polypeptide Polymers 0.000 claims description 33
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 33
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 33
• 238000000034 method Methods 0.000 claims description 27
• 239000002157 polynucleotide Substances 0.000 claims description 20
• 102000040430 polynucleotide Human genes 0.000 claims description 20
• 108091033319 polynucleotide Proteins 0.000 claims description 20
• 241000894006 Bacteria Species 0.000 claims description 13
• 230000003308 immunostimulating effect Effects 0.000 claims description 8
• 108700010013 HMGB1 Proteins 0.000 claims description 7
• 150000001413 amino acids Chemical class 0.000 claims description 7
• 101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 claims description 6
• 101150021904 HMGB1 gene Proteins 0.000 claims description 6
• 230000028993 immune response Effects 0.000 claims description 6
• 239000008194 pharmaceutical composition Substances 0.000 claims description 6
• 239000012634 fragment Substances 0.000 claims description 5
• 241000588722 Escherichia Species 0.000 claims description 4
• 241000607142 Salmonella Species 0.000 claims description 4
• 230000000890 antigenic effect Effects 0.000 claims description 4
• 244000144977 poultry Species 0.000 claims description 4
• 241000894007 species Species 0.000 claims description 4
• 230000002708 enhancing effect Effects 0.000 claims description 3
• 208000015181 infectious disease Diseases 0.000 claims description 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
• 241000193830 Bacillus <bacterium> Species 0.000 claims description 2
• 101150013553 CD40 gene Proteins 0.000 claims description 2
• 241000588923 Citrobacter Species 0.000 claims description 2
• 241000588698 Erwinia Species 0.000 claims description 2
• 241000287828 Gallus gallus Species 0.000 claims description 2
• 241000588748 Klebsiella Species 0.000 claims description 2
• 241000186660 Lactobacillus Species 0.000 claims description 2
• 241000588768 Providencia Species 0.000 claims description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
• 241000607768 Shigella Species 0.000 claims description 2
• 230000005867 T cell response Effects 0.000 claims description 2
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 2
• 241000607598 Vibrio Species 0.000 claims description 2
• 241000700605 Viruses Species 0.000 claims description 2
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
• 230000005875 antibody response Effects 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 230000002163 immunogen Effects 0.000 claims description 2
• 238000007918 intramuscular administration Methods 0.000 claims description 2
• 239000002502 liposome Substances 0.000 claims description 2
• 125000006850 spacer group Chemical group 0.000 claims description 2
• 238000007920 subcutaneous administration Methods 0.000 claims description 2
• 102100037907 High mobility group protein B1 Human genes 0.000 claims 2
• 102000055207 HMGB1 Human genes 0.000 description 5
• 102100029989 SHC SH2 domain-binding protein 1 Human genes 0.000 description 5
• 210000004027 cell Anatomy 0.000 description 5
• 210000000680 phagosome Anatomy 0.000 description 4
• 230000001580 bacterial effect Effects 0.000 description 3
• 210000002540 macrophage Anatomy 0.000 description 3
• 230000000242 pagocytic effect Effects 0.000 description 3
• 108091006146 Channels Proteins 0.000 description 2
• 102000034573 Channels Human genes 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
• 239000000427 antigen Substances 0.000 description 2
• 102000036639 antigens Human genes 0.000 description 2
• 108091007433 antigens Proteins 0.000 description 2
• 241000588724 Escherichia coli Species 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 210000003712 lysosome Anatomy 0.000 description 1
• 230000001868 lysosomic effect Effects 0.000 description 1
• 230000012846 protein folding Effects 0.000 description 1
• 102000004169 proteins and genes Human genes 0.000 description 1
• 108090000623 proteins and genes Proteins 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1